• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰化区分疾病特异性 tau 沉积。

Acetylation discriminates disease-specific tau deposition.

机构信息

German Center for Neurodegenerative Diseases (DZNE), Von-Siebold-Str. 3a, 37075, Göttingen, Germany.

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

出版信息

Nat Commun. 2023 Sep 22;14(1):5919. doi: 10.1038/s41467-023-41672-1.

DOI:10.1038/s41467-023-41672-1
PMID:37739953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10517010/
Abstract

Pathogenic aggregation of the protein tau is a hallmark of Alzheimer's disease and several other tauopathies. Tauopathies are characterized by the deposition of specific tau isoforms as disease-related tau filament structures. The molecular processes that determine isoform-specific deposition of tau are however enigmatic. Here we show that acetylation of tau discriminates its isoform-specific aggregation. We reveal that acetylation strongly attenuates aggregation of four-repeat tau protein, but promotes amyloid formation of three-repeat tau. We further identify acetylation of lysine 298 as a hot spot for isoform-specific tau aggregation. Solid-state NMR spectroscopy demonstrates that amyloid fibrils formed by unmodified and acetylated three-repeat tau differ in structure indicating that site-specific acetylation modulates tau structure. The results implicate acetylation as a critical regulator that guides the selective aggregation of three-repeat tau and the development of tau isoform-specific neurodegenerative diseases.

摘要

蛋白 tau 的致病聚集是阿尔茨海默病和几种其他 tau 病的标志。tau 病的特征是特定的 tau 同工型作为与疾病相关的 tau 丝结构沉积。然而,决定 tau 同工型特异性沉积的分子过程仍然是个谜。在这里,我们表明 tau 的乙酰化可区分其同工型特异性聚集。我们揭示了乙酰化强烈抑制四重复 tau 蛋白的聚集,但促进三重复 tau 的淀粉样形成。我们进一步确定赖氨酸 298 的乙酰化为同工型特异性 tau 聚集的热点。固态 NMR 光谱表明,未修饰和乙酰化的三重复 tau 形成的淀粉样纤维在结构上存在差异,表明特异性位点的乙酰化调节 tau 结构。结果表明,乙酰化是一种关键的调节剂,指导三重复 tau 的选择性聚集和 tau 同工型特异性神经退行性疾病的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/94196f3a505d/41467_2023_41672_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/e564642a91ea/41467_2023_41672_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/688e3856a071/41467_2023_41672_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/4110d7d11956/41467_2023_41672_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/204dd6b49c8b/41467_2023_41672_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/9de704996129/41467_2023_41672_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/94196f3a505d/41467_2023_41672_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/e564642a91ea/41467_2023_41672_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/688e3856a071/41467_2023_41672_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/4110d7d11956/41467_2023_41672_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/204dd6b49c8b/41467_2023_41672_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/9de704996129/41467_2023_41672_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4756/10517010/94196f3a505d/41467_2023_41672_Fig6_HTML.jpg

相似文献

1
Acetylation discriminates disease-specific tau deposition.乙酰化区分疾病特异性 tau 沉积。
Nat Commun. 2023 Sep 22;14(1):5919. doi: 10.1038/s41467-023-41672-1.
2
Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.乙酰化 tau,阿尔茨海默病和其他 tau 病的新型病理特征。
Brain. 2012 Mar;135(Pt 3):807-18. doi: 10.1093/brain/aws013.
3
An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.一种调节tau蛋白聚集倾向和功能的乙酰化-磷酸化开关。
J Biol Chem. 2017 Sep 15;292(37):15277-15286. doi: 10.1074/jbc.M117.794602. Epub 2017 Jul 31.
4
Deciphering the Effect of Lysine Acetylation on the Misfolding and Aggregation of Human Tau Fragment IPAKTPPAPK Using Molecular Dynamic Simulation and the Markov State Model.解析赖氨酸乙酰化对人 Tau 片段 IPAKTPPAPK 错误折叠和聚集的影响:分子动力学模拟和马科夫状态模型的应用。
Int J Mol Sci. 2022 Feb 22;23(5):2399. doi: 10.3390/ijms23052399.
5
Charge neutralization of lysine via carbamylation reveals hidden aggregation hot-spots in tau protein flanking regions.通过氨甲酰化使赖氨酸电荷中和揭示了tau蛋白侧翼区域隐藏的聚集热点。
FEBS J. 2022 May;289(9):2562-2577. doi: 10.1111/febs.16284. Epub 2021 Dec 2.
6
Disease-associated patterns of acetylation stabilize tau fibril formation.疾病相关的乙酰化模式稳定了 tau 纤维的形成。
Structure. 2023 Sep 7;31(9):1025-1037.e4. doi: 10.1016/j.str.2023.05.020. Epub 2023 Jun 21.
7
Tauopathy: A common mechanism for neurodegeneration and brain aging.tau 病:神经退行性变和大脑老化的常见机制。
Mech Ageing Dev. 2019 Mar;178:72-79. doi: 10.1016/j.mad.2019.01.007. Epub 2019 Jan 19.
8
Cryo-EM structures of tau filaments.tau 纤维的冷冻电镜结构。
Curr Opin Struct Biol. 2020 Oct;64:17-25. doi: 10.1016/j.sbi.2020.05.011. Epub 2020 Jun 27.
9
Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.人源tau 病相关 tau 株决定了被招募用于模板扩增的底物。
Brain. 2021 Sep 4;144(8):2333-2348. doi: 10.1093/brain/awab091.
10
Specific post-translational modifications of soluble tau protein distinguishes Alzheimer's disease and primary tauopathies.可溶性 tau 蛋白的特定翻译后修饰可区分阿尔茨海默病和原发性 tau 病。
Nat Commun. 2023 Jun 22;14(1):3706. doi: 10.1038/s41467-023-39328-1.

引用本文的文献

1
Decoding tau acetylation in Alzheimer's disease and tauopathies: from site-specific mechanisms to therapeutic horizons.解析阿尔茨海默病和tau蛋白病中的tau蛋白乙酰化:从位点特异性机制到治疗前景
BMB Rep. 2025 Aug;58(8):325-339.
2
Role of saturated fatty acid metabolism in posttranslational modifications of the Tau protein.饱和脂肪酸代谢在Tau蛋白翻译后修饰中的作用。
Mol Cell Biochem. 2025 Apr 10. doi: 10.1007/s11010-025-05275-2.
3
The evolving role of solid state nuclear magnetic resonance methods in studies of amyloid fibrils.固态核磁共振方法在淀粉样纤维研究中不断演变的作用。

本文引用的文献

1
TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy.结节性硬化症复合物1(TSC1)缺失通过诱导tau蛋白乙酰化并阻止伴侣蛋白介导的自噬清除tau蛋白,增加了患tau蛋白病的风险。
Sci Adv. 2021 Nov 5;7(45):eabg3897. doi: 10.1126/sciadv.abg3897.
2
Structure-based classification of tauopathies.基于结构的tau 病分类。
Nature. 2021 Oct;598(7880):359-363. doi: 10.1038/s41586-021-03911-7. Epub 2021 Sep 29.
3
Co-factor-free aggregation of tau into seeding-competent RNA-sequestering amyloid fibrils.
Curr Opin Struct Biol. 2025 Jun;92:103043. doi: 10.1016/j.sbi.2025.103043. Epub 2025 Apr 7.
4
Shapeshifter W-Tau Peptide Inhibits Tau Aggregation and Disintegrates Paired Helical Filaments.变形体W-Tau肽抑制 Tau 聚集并分解成对螺旋丝。
Biochemistry. 2025 Apr 15;64(8):1841-1851. doi: 10.1021/acs.biochem.4c00809. Epub 2025 Mar 26.
5
O-GlcNAc modification differentially regulates microtubule binding and pathological conformations of tau isoforms in vitro.O-连接的N-乙酰葡糖胺修饰在体外差异调节微管结合及tau异构体的病理构象。
J Biol Chem. 2025 Mar;301(3):108263. doi: 10.1016/j.jbc.2025.108263. Epub 2025 Feb 3.
6
Histone Deacetylation in Alzheimer's Diseases (AD); Hope or Hype.阿尔茨海默病(AD)中的组蛋白去乙酰化:希望还是炒作?
Cell Biochem Biophys. 2025 Jun;83(2):1537-1553. doi: 10.1007/s12013-025-01670-0. Epub 2025 Jan 18.
7
Non-enzymatic posttranslational protein modifications in protein aggregation and neurodegenerative diseases.蛋白质聚集和神经退行性疾病中的非酶促翻译后蛋白质修饰
RSC Chem Biol. 2024 Dec 19;6(2):129-149. doi: 10.1039/d4cb00221k. eCollection 2025 Feb 5.
8
Cellular and pathological functions of tau.tau蛋白的细胞与病理功能
Nat Rev Mol Cell Biol. 2024 Nov;25(11):845-864. doi: 10.1038/s41580-024-00753-9. Epub 2024 Jul 16.
9
Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review.tau 蛋白在神经退行性疾病中的作用及其靶向药物的开发:文献综述。
Molecules. 2024 Jun 13;29(12):2812. doi: 10.3390/molecules29122812.
10
Hyperacetylation mimetics within the tau filament core inhibits prion-like propagation of misfolded tau.tau蛋白细丝核心内的超乙酰化模拟物可抑制错误折叠的tau蛋白的朊病毒样传播。
bioRxiv. 2024 Apr 15:2024.04.12.589253. doi: 10.1101/2024.04.12.589253.
无辅助因子的 tau 聚集形成具有种子能力的 RNA 结合淀粉样原纤维。
Nat Commun. 2021 Jul 9;12(1):4231. doi: 10.1038/s41467-021-24362-8.
4
Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice.乙酰化 tau 抑制伴侣介导的自噬并促进小鼠 tau 病理传播。
Nat Commun. 2021 Apr 14;12(1):2238. doi: 10.1038/s41467-021-22501-9.
5
Reducing acetylated tau is neuroprotective in brain injury.减少乙酰化 tau 对脑损伤具有神经保护作用。
Cell. 2021 May 13;184(10):2715-2732.e23. doi: 10.1016/j.cell.2021.03.032. Epub 2021 Apr 13.
6
Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation.tau蛋白的翻译后修饰:tau蛋白功能、降解及聚集的动态转变因素
Front Neurol. 2021 Jan 7;11:595532. doi: 10.3389/fneur.2020.595532. eCollection 2020.
7
Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease.在神经退行性疾病中淀粉样蛋白多形体的分级化学测定。
Nat Chem Biol. 2021 Mar;17(3):237-245. doi: 10.1038/s41589-020-00708-z. Epub 2021 Jan 11.
8
Comparison of Common and Disease-Specific Post-translational Modifications of Pathological Tau Associated With a Wide Range of Tauopathies.与多种tau蛋白病相关的病理性tau蛋白常见和疾病特异性翻译后修饰的比较。
Front Neurosci. 2020 Nov 4;14:581936. doi: 10.3389/fnins.2020.581936. eCollection 2020.
9
An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline.一种依赖于组蛋白去乙酰化酶 6 的监控机制可以抑制 tau 介导的神经退行性病变和认知能力下降。
Nat Commun. 2020 Nov 2;11(1):5522. doi: 10.1038/s41467-020-19317-4.
10
Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer's disease patients.阿尔茨海默病患者海马体和前额叶皮层中组蛋白乙酰化途径的失调。
Eur Neuropsychopharmacol. 2020 Apr;33:101-116. doi: 10.1016/j.euroneuro.2020.01.015. Epub 2020 Feb 11.